Literature DB >> 20646234

Increase of ZASC1 gene copy number in recurrent oral carcinoma.

W-F Chiang1, P-S Hung, S-Y Liu, T-C Yuan, K-W Chang, Y-P Chen, Y-C Liu, S-C Lin.   

Abstract

BACKGROUNDS: The chromosome 3q26 locus is a hotspot region carrying oncogenes that frequently altered in neoplasms. ZASC1 is a zinc finger protein transcription factor localized on 3q26. Our previous study showed the frequent amplification of 3q26, including the ZASC1 gene, in oral squamous cell carcinoma (OSCC). This study investigated the copy number changes of ZASC1 gene from primary to recurrent OSCC and the functions of ZASC1 in OSCC cells.
MATERIALS AND METHODS: A total of 27 OSCC patients with primary and recurrent tumors were examined for ZASC1 and TERC copy number changes using Quantitative PCR analysis. Exogenous expression and knockdown of ZASC1 were carried out to specify the oncogenic potential of ZASC1 in OSCC cells.
RESULTS: A ZASC1 copy number that has increased from primary to recurrent tumor counterparts in tissue pairs suggested the importance of ZASC1 in tumor progression. The increase of ZASC1 gene copy number in recurrent tumors was associated with the consumption of betel quid in patients. OSCC cells expressing ZASC1-FLAG fusion protein showed increased proliferation. After the knockdown of endogenous ZASC1 expression using small interference RNA, the growth and colony formation of SAS OSCC cells decreased.
CONCLUSIONS: The findings support the hypothesis that ZASC1 localized on 3q26 contributes to the recurrence of OSCC.
© 2010 John Wiley & Sons A/S.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 20646234     DOI: 10.1111/j.1601-0825.2010.01702.x

Source DB:  PubMed          Journal:  Oral Dis        ISSN: 1354-523X            Impact factor:   3.511


  9 in total

Review 1.  The Role of Zinc Finger Proteins in Various Oral Conditions.

Authors:  Rupali Agnihotri; Sumit Gaur
Journal:  ScientificWorldJournal       Date:  2022-04-15

2.  Genomic alterations in breast cancer patients in betel quid and non betel quid chewers.

Authors:  Mishi Kaushal; Ashwani K Mishra; Jagannath Sharma; Eric Zomawia; Amal Kataki; Sujala Kapur; Sunita Saxena
Journal:  PLoS One       Date:  2012-08-24       Impact factor: 3.240

3.  Emerging landscape of oncogenic signatures across human cancers.

Authors:  Giovanni Ciriello; Martin L Miller; Bülent Arman Aksoy; Yasin Senbabaoglu; Nikolaus Schultz; Chris Sander
Journal:  Nat Genet       Date:  2013-10       Impact factor: 38.330

4.  ZASC1 stimulates HIV-1 transcription elongation by recruiting P-TEFb and TAT to the LTR promoter.

Authors:  James W Bruce; Rachel Reddington; Elizabeth Mathieu; Megan Bracken; John A T Young; Paul Ahlquist
Journal:  PLoS Pathog       Date:  2013-10-24       Impact factor: 6.823

5.  MiR-222 targeted PUMA to improve sensitization of UM1 cells to cisplatin.

Authors:  Fangfang Jiang; Wei Zhao; Lijie Zhou; Zifeng Liu; Wenqing Li; Dongsheng Yu
Journal:  Int J Mol Sci       Date:  2014-12-02       Impact factor: 5.923

6.  ZBTB2 represses HIV-1 transcription and is regulated by HIV-1 Vpr and cellular DNA damage responses.

Authors:  James W Bruce; Megan Bracken; Edward Evans; Nathan Sherer; Paul Ahlquist
Journal:  PLoS Pathog       Date:  2021-02-26       Impact factor: 7.464

Review 7.  Association of betel nut with carcinogenesis: revisit with a clinical perspective.

Authors:  Rajeshwar N Sharan; Ravi Mehrotra; Yashmin Choudhury; Kamlesh Asotra
Journal:  PLoS One       Date:  2012-08-13       Impact factor: 3.240

8.  Differences in gene expression between mouse and human for dynamically regulated genes in early embryo.

Authors:  Elo Madissoon; Virpi Töhönen; Liselotte Vesterlund; Shintaro Katayama; Per Unneberg; Jose Inzunza; Outi Hovatta; Juha Kere
Journal:  PLoS One       Date:  2014-08-04       Impact factor: 3.240

9.  Genomic and Transcriptomic Characterization Links Cell Lines with Aggressive Head and Neck Cancers.

Authors:  Hui Cheng; Xinping Yang; Han Si; Anthony D Saleh; Wenming Xiao; Jamie Coupar; Susanne M Gollin; Robert L Ferris; Natalia Issaeva; Wendell G Yarbrough; Mark E Prince; Thomas E Carey; Carter Van Waes; Zhong Chen
Journal:  Cell Rep       Date:  2018-10-30       Impact factor: 9.423

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.